Ophthalmologists Invited To Participate in Betadine for EKC Treat...( LITTLE SILVER N.J. July 2 /- Dr Danie...),Health

LITTLE SILVER, N.J., July 2 /PRNewswire/ -- Dr Daniel Goldberg, a leading New Jersey ophthalmologist is coordinating a new study to measure the effectiveness of using 5% Betadine irrigation for treatment of acute EKC -- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.

Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study. The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC.

The study is being coordinated by Dr Daniel Goldberg, Clinical Associate Professor of Ophthalmology, Drexel College of Medicine as well as committee and staff members of Atlantic Eye Physicians, in Long Branch, Little Silver, and Holmdel New Jersey. This protocol is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx

Information on registration is available at http://www.betadineforekc.com/s
'/>"/>